Development of Gene Editing Strategies for Human β-Globin (HBB) Gene Mutations

Author:

Kalkan Batuhan Mert,Kala Ezgi Yagmur,Yuce Melek,Alpaslan Medine Karadag,Kocabas Fatih

Abstract

AbstractRecent developments in gene editing technology have enabled scientists to modify DNA sequence by using engineered endonucleases. These gene editing tools are promising candidates for clinical applications, especially for treatment of inherited disorders like sickle cell disease (SCD). SCD is caused by a point mutation in human β-globin gene (HBB). Clinical strategies have demonstrated substantial success, however there is not any permanent cure for SCD available. CRISPR/Cas9 platform uses a single endonuclease and a single guide RNA (gRNA) to induce sequence-specific DNA double strand break (DSB). When this accompanies a repair template, it allows repairing the mutated gene. In this study, it was aimed to target HBB gene via CRISPR/Cas9 genome editing tool to introduce nucleotide alterations for efficient genome editing and correction of point mutations causing SCD in human cell line, by Homology Directed Repair (HDR). We have achieved to induce target specific nucleotide changes on HBB gene in the locus of mutation causing SCD. The effect of on-target activity of bone fide standard gRNA and newly developed longer gRNA were examined. It is observed that longer gRNA has higher affinity to target DNA while having the same performance for targeting and Cas9 induced DSBs. HDR mechanism was triggered by co-delivery of donor DNA repair templates in circular plasmid form. In conclusion, we have suggested methodological pipeline for efficient targeting with higher affinity to target DNA and generating desired modifications on HBB gene. Graphical abstractHighlightsHBB gene were targeted by spCas9 in close proximity to the SCD mutationLong gRNA, which is designed to target SCD mutation, is sickle cell disease specific and exhibits indistinguishable level of cleavage activity on target locus.Functional HBB HDR repair templates with 1 Kb and 2 Kb size were generated to cover all known mutations in the HBB gene.Replacement of PAM sequence in HDR template with HindIII recognition sequence allowed a quick assessment of the HDR efficiency.HDR template: Cas9-GFP vector 2:1 ratio yielded the highest HDR events/GFP+ cells.

Publisher

Cold Spring Harbor Laboratory

Reference56 articles.

1. Aksoz, M. , Albayrak, E. , Aslan, G.S. , Turan, R.D. , Alyazici, L.Y. , Siyah, P. , Tusuz, E.C. , Canikyan, S. , Yucel, D. , Meric, N. , et al. (2018). c-Myc inhibitor 10074-G5 induces murine and human hematopoietic stem and progenitor cell expansion and HDR modulator Rad51 expression. Current cancer drug targets.

2. Current therapy of sickle cell disease;Haematologica,2006

3. Distribution of hemoglobinopathies in Turkey. Report based on studies conducted at the Hacettepe Children’s Hospital and the reviews of other studies;The Turkish journal of pediatrics,1986

4. Antony, J.S. , Latifi, N. , Haque, A.K.M.A. , Lamsfus-Calle, A. , Daniel-Moreno, A. , Graeter, S. , Baskaran, P. , Weinmann, P. , Mezger, M. , Handgretinger, R. , et al. (2018). Gene correction of HBB mutations in CD34+ hematopoietic stem cells using Cas9 mRNA and ssODN donors. Molecular and Cellular Pediatrics 5.

5. Sickle Hemoglobin (Hb S) Allele and Sickle Cell Disease: A HuGE Review

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3